Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009-Reference-Cited by-同舟云学术

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009

Published:2015-05-01 Issue:2 Volume:1 Page:158
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Dinan Michaela A.¹,Mi Xiaojuan²,Reed Shelby D.¹,Hirsch Bradford R.¹,Lyman Gary H.³,Curtis Lesley H.⁴

Affiliation:

1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina2Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina3Department of Medicine, Duke University School of Medicine, Durham, North Caroli

2. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina

3. Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences Division and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington5Division of Medical Oncology, Department of Medicine, University of Washington S

4. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina3Department of Medicine, Duke University School of Medicine, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a clinical breast cancer tool for accurate prediction of recurrence;npj Breast Cancer;2024-06-15

2. Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer;npj Breast Cancer;2023-06-08

3. Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review;PLOS ONE;2023-03-10

4. Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay;Breast Cancer Research and Treatment;2023-03-09

5. Hospital Rurality and Gene Expression Profiling for Early-Stage Breast Cancer among Iowa Residents (2010–2018);The Breast Journal;2022-08-30